Literature DB >> 11845546

Advanced cardiac life support antiarrhythmic drugs.

Peter J Kudenchuk1.   

Abstract

As exemplified in this discussion of ACLS antiarrhythmic drugs, the evidence-based evaluation process has created a high standard for the acceptance and ranking of therapies for cardiac arrest. This process also has identified critical areas needing further investigation, fostered a healthy sense of discomfort with the adequacy of our present interventions for cardiac arrest, and hopefully will continue to spur the science while sifting the dogma out of CPR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845546     DOI: 10.1016/s0733-8651(03)00066-3

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  4 in total

1.  [Life-threatening brady- and tachyarrhythmias].

Authors:  H-J Trappe
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

2.  Treating critical supraventricular and ventricular arrhythmias.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

3.  Concept of the five 'A's for treating emergency arrhythmias.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

Review 4.  Advances in the acute pharmacologic management of cardiac arrhythmias.

Authors:  Andrea Sarkozy; Paul Dorian
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.